TickerRisk
Learn Pricing Open Scanner

AMGEN INC (AMGN) Options Risk Score

Real-time risk analysis for AMGN options traders — updated every 30 minutes.

84
HIGH Risk
51.7
IV Rank
32.5%
IV %
2026-11-03
Next Earnings
Biological Products, (No Diagnostic Substances)
Sector

Data last updated: 2026-10-21

Run a full AMGN options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.


Scan AMGN Now — Free →

Is it risky to sell options on AMGEN INC (AMGN) right now?

AMGEN INC (AMGN) currently scores 84 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. That score is driven by an upcoming earnings report, 5 recent news items, 10 active legal filings and 16 clinical-trial catalysts falling inside the 4-week window. A HIGH reading (70+) means AMGN has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.

AMGN shows an IV Rank of 52, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 33%. IV Rank is the most useful figure for deciding whether to sell or buy premium on AMGN.

AMGN reports on 2026-11-03. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

AMGEN INC (AMGN) current implied volatility and IV Rank

As of the latest scan, AMGEN INC (AMGN) shows an IV Rank of 52 with implied volatility around 33%, alongside a TickerRisk options-risk score of 84/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about AMGN's options, see IV Rank explained.

AMGEN INC (AMGN) next earnings date — 2026-11-03

AMGEN INC (AMGN) is scheduled to report on 2026-11-03 — about 13 days away, so a standard expiry would carry straight through it. AMGN's IV Rank is currently 52. Implied volatility tends to build into the date and drop sharply once results are public. If the premium on AMGN looks unusually generous right now, this is the most likely reason.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer